SCHEMBL1664480

SCHEMBL1664480

OC1CCN(c2ccc(Nc3ccc(Nc4cc[c]cc4)cc3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
JAK2 O60674 4/20 0.43
JAK3 P52333 2/20 0.43
HPGDS O60760 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.41
LRRK2 Q5S007 2/20 0.40
DCLK1 O15075 1/20 0.40
STAT6 P42226 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
WEE1 P30291 2/20 0.39
FGFR1 P11362 1/20 0.39
CDK4 P11802 1/20 0.39
CCNA2 P20248 1/20 0.39
FGFR2 P21802 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL444546 0.84 L3MBTL3 (0.41) L3MBTL1LMNAMAPTHPGDSL3MBTL3
SCHEMBL1663874 0.78 WEE1 (0.46) SYKLMNAMAPTJAK2JAK3
SCHEMBL8769706 0.77 RAB9A (0.58) L3MBTL1LMNAMAPTSMN1; SMN2
SCHEMBL31003565 0.73 HPGDS (0.43) SYKGAAMAPTJAK2JAK3
SCHEMBL27729955 0.73 SMN1; SMN2 (0.42) SYKL3MBTL1GAAMAPTJAK2
SCHEMBL24609549 0.73 SMN1; SMN2 (0.49) L3MBTL1LMNAGAAMAPTJAK2
SCHEMBL2479186 0.73 AR (0.50) CDK2
SCHEMBL17353206 0.73 AR (0.50) CDK2
SCHEMBL2958737 0.72 TDP1 (0.53) L3MBTL1LMNAGAAMAPTL3MBTL3
SCHEMBL18745976 0.72 KMT2A (0.55) L3MBTL1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed